Zimmer is latest medtech firm to lower expected tariff hit

CFO Suketu Upadhyay said the company now expects a charge in 2025 of about $40 million, compared with a range of $60 million to $80 million.

BD commits $35M to expand US syringe production plant

The company said it has grown capacity by 10% this year, bringing its total U.S. output of the prefilled flush syringes to above 750 million units.

Trump plans 100% tariffs for semiconductor imports

Chips are one of several product types currently under Section 232 investigation by the White House, a frequent precursor to duties.

Medical device industry says future MDUFA hikes unsustainable

Device lobbyists’ priorities contrasted with patient advocates, who sought an increase in user fees and more funds for postmarket safety.

Philips BiPAP machine recall associated with 8 deaths

Philips sent updated instructions after disclosing problems last year with an alarm that can interrupt treatment for people with obstructive sleep apnea or respiratory insufficiency.

Exact Sciences acquires rights to rival Freenome’s blood-based colon cancer test

The great Medicare Advantage contraction appears set to continue

US to levy another 25% tariff on India imports